Drug proving of homoeopathic drug Strychnos potatorum 6

Detailed screening, documentation and evaluation of the action of Strychnos Potatorum with the aid of Double Blind Placebo Controlled Human Pathogenetic Trail â?? Drug Proving

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027744

Enrollment

Registered

2020-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Strychnos Potatorum 6: Each doses composed of 4 globules number 10 will be given daily for 4 times in a day that is four hourly till the symptoms appear maximum for 3 days that is 12 d

Eligibility

Inclusion criteria

Inclusion criteria: Apparent good state of health both physically and mentally Healthy individual with no apparent disease at the time of screening Healthy individual considered as fit by the specialists Intelligent enough so as to be able to notice and record the changes or symptoms 18 years to 60 years of age Both sexes Able to be informed of the nature of study Willing to give written informed consent to participate

Exclusion criteria

Exclusion criteria: Diseased condition of persons like haematological, pulmonary, cardiac, renal, dermatological, endocrine, neurological, immunological and gastro intestinal etc. Person having colour blindness Person undergone surgery in last 2 months Planed medicinal or dental treatment or taking any substance that may interfere with the proving substance Persons on regular medication Person must not be on homoeopathic medication in last one month. Other conditions: History of allergy (including food also) , woman in pregnancy, woman in lactating period & puerperium, hysterectomy Emotionally disturbed, hysterical & anxious person. Bad habits Like smoking (more than 10 cigarettes/day), alcoholism, drug abuse If the person is participants of another proving in last 6 months Does not having time for regular reporting of health status

Design outcomes

Primary

Measure	Time frame
To acquire knowledge of homoeopathic therapeutic values of the drug Strychnos potatorum through the process of Human Pathogenetic trial (Drug Proving)Timepoint: 1 year	—

Secondary

Measure	Time frame
To find out the applicability of the drug Strychnos potatorum in various clinical conditionsTimepoint: 1 year	—

Countries

India

Contacts

Public ContactDr Rajat Chattopadhyay

The Calcutta Homoeopathic Medical College and Hospital

dr.rajatchatterjee@gmail.com9331041142

Outcome results